A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China
NCT07040306
·
clinicaltrials.gov ↗
RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Graves´ Disease
Interventions
DRUG:
Methimazole(MMI)
Sponsor
First Hospital of China Medical University